- Stocks
- Pharma & Healthcare
- Dolphin Medical
Dolphin Medical share price
NSE: DOLPHMEDPharma & HealthcareDiagnostics & Research
Dolphin Medical at a glance
With a market capitalisation of ₹12 Cr, it ranks 3824th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Diagnostics & Research.
Its return on equity was −0.4% in FY16.
Key numbers
- Market cap
- ₹12 CrRank 3824 on NSE
- Price to book
- 0.14×FY16
- ROE
- −0.4%FY16
- ROCE
- −0.2%FY16
- Debt to equity
- 0.64FY16
- Net profit margin
- −8.2%FY16
- Book value / share
- ₹8.50FY16
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | — | — | — | — | — |
Dolphin Medical financials
| Item | FY11 | FY12 | FY13 | FY14 | FY15 | FY16 |
|---|---|---|---|---|---|---|
| Revenue | ₹4 Cr | ₹4 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr |
| Operating profit | ₹0 Cr | −₹1 Cr | −₹2 Cr | −₹1 Cr | −₹1 Cr | −₹0 Cr |
| Net profit | ₹0 Cr | −₹1 Cr | −₹2 Cr | −₹1 Cr | −₹1 Cr | −₹0 Cr |
| EPS (₹) | ₹10.00 | −₹1.00 | −₹1.00 | −₹1.00 | ₹0.00 | ₹0.00 |
| Cash from operations | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | −₹0 Cr |
| Total debt | ₹7 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr |
| Shareholders' equity | ₹18 Cr | ₹16 Cr | ₹14 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr |
Dolphin Medical vs peers
The listed Pharma & Healthcare companies nearest to Dolphin Medical by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| STARSOURCEStarsource Mult | — | — | — | ₹14 Cr | — | — |
| NORRISNorris Medicine | — | — | — | ₹14 Cr | — | — |
| DOLPHMEDDolphin Medical | — | — | — | ₹12 Cr | — | — |
| ORTINGLOBEORTIN GLOBAL | ₹13.53 | −6.04% | +16.6% | ₹11 Cr | — | — |
| BERLDRGBeryl Drugs | — | — | — | ₹11 Cr | — | — |
| GLHRLGlobal Longlife | — | — | — | ₹10 Cr | — | — |
| LOOKSLooks Health | — | — | — | ₹10 Cr | — | — |
Ask anything about Dolphin Medical
Pivot answers on the live chart with evidence you can check, and tests strategies against DOLPHMED's own history. Try: “Why has DOLPHMED moved over the last three months?” · “Backtest a 50-day moving-average crossover on DOLPHMED over five years” · “Compare DOLPHMED with STARSOURCE on margins and valuation”
Frequently asked questions about Dolphin Medical
What is the market cap of Dolphin Medical?
Dolphin Medical's market capitalisation is ₹12 Cr (₹12 Cr) at the 22 Oct 2026 close, ranking 3824th among the NSE companies Pivot tracks.
What is the ROE and ROCE of Dolphin Medical?
Return on equity was −0.4% in FY16 and return on capital employed was −0.2% in FY16 (consolidated figures).
Is Dolphin Medical a debt-free company?
No. Dolphin Medical's debt-to-equity ratio was 0.64 in FY16, with total debt of ₹8 Cr.
Who are Dolphin Medical's competitors?
The listed Pharma & Healthcare companies closest to Dolphin Medical by market cap are Starsource Mult, Norris Medicine, ORTIN GLOBAL, Beryl Drugs, Global Longlife and Looks Health.
Is Dolphin Medical a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Dolphin Medical's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on DOLPHMED against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with D · all NSE stocks · this page as text